FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2969870895> ?p ?o ?g. }

• W2969870895 endingPage "340.e4" @default.
• W2969870895 startingPage "330" @default.
• W2969870895 abstract "Intracavitary chemotherapy is a promising concept to improve local tumor control for malignant pleural mesothelioma with reported high morbidity rates. We have demonstrated that administration of cisplatin loaded to fibrin increased local drug concentration and reduced systemic toxicity in preclinical models. We present a phase I trial of intracavitary cisplatin-fibrin after surgical tumor resection.A total of 12 patients (75% International Mesothelioma Interest Group stage III-IV) were treated with 4 dose levels of intracavitary cisplatin-fibrin (11-44 mg/m2 body surface area) in a dose-escalating design. Cisplatin-fibrin was sprayed on the resected surfaces after pleurectomy/decortication. Blood and tissue samples were taken to assess toxicity and pharmacokinetics. Patients were regularly followed up.No dose-limiting toxicity was observed. Major morbidity occurred in 4 patients (33%). The 30-day and 90-day mortality were both 0%. Of 80 adverse events, 9 were classified serious, but none of these were related to study treatment. Local cisplatin concentration in the chest wall tissue was high at all dose levels (median, 46.3 μg/g [12-133 μg/g]). In serum, median cisplatin area under the concentration time curve values were always below renal toxicity levels. The median overall survival with 95% confidence interval was 21 months (10-31 months). In 1 patient with epithelioid malignant pleural mesothelioma (International Mesothelioma Interest Group stage I), there was no sign of relapse 48 months after treatment (44 mg/m2 body surface area).The administration of intracavitary cisplatin-fibrin is safe with favorable pharmacokinetics. Although most patients had advanced disease, long-term outcomes are comparable to other multimodal concepts. A confirmation phase II trial is ongoing." @default.
• W2969870895 created "2019-08-29" @default.
• W2969870895 creator A5007014216 @default.
• W2969870895 creator A5012411744 @default.
• W2969870895 creator A5018686666 @default.
• W2969870895 creator A5034219005 @default.
• W2969870895 creator A5047142547 @default.
• W2969870895 creator A5076345819 @default.
• W2969870895 creator A5082888818 @default.
• W2969870895 creator A5084594418 @default.
• W2969870895 creator A5087464605 @default.
• W2969870895 date "2020-01-01" @default.
• W2969870895 modified "2023-09-25" @default.
• W2969870895 title "Intracavitary cisplatin-fibrin chemotherapy after surgery for malignant pleural mesothelioma: A phase I trial" @default.
• W2969870895 cites W1801906647 @default.
• W2969870895 cites W1952855159 @default.
• W2969870895 cites W1963582513 @default.
• W2969870895 cites W1967600334 @default.
• W2969870895 cites W1973548335 @default.
• W2969870895 cites W1976797731 @default.
• W2969870895 cites W1978636222 @default.
• W2969870895 cites W1989589777 @default.
• W2969870895 cites W2017959023 @default.
• W2969870895 cites W2030634678 @default.
• W2969870895 cites W2034194552 @default.
• W2969870895 cites W2044411373 @default.
• W2969870895 cites W2058949714 @default.
• W2969870895 cites W2062044625 @default.
• W2969870895 cites W2062763309 @default.
• W2969870895 cites W2068244585 @default.
• W2969870895 cites W2075574479 @default.
• W2969870895 cites W2086941176 @default.
• W2969870895 cites W2089218862 @default.
• W2969870895 cites W2091681936 @default.
• W2969870895 cites W2097851464 @default.
• W2969870895 cites W2098937949 @default.
• W2969870895 cites W2102791346 @default.
• W2969870895 cites W2105015900 @default.
• W2969870895 cites W2113220153 @default.
• W2969870895 cites W2138647267 @default.
• W2969870895 cites W2141844053 @default.
• W2969870895 cites W2170145639 @default.
• W2969870895 cites W2170977668 @default.
• W2969870895 cites W2171227985 @default.
• W2969870895 cites W2293035635 @default.
• W2969870895 cites W2400028257 @default.
• W2969870895 cites W2586707081 @default.
• W2969870895 cites W2783708904 @default.
• W2969870895 cites W72357302 @default.
• W2969870895 doi "https://doi.org/10.1016/j.jtcvs.2019.07.073" @default.
• W2969870895 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31590949" @default.
• W2969870895 hasPublicationYear "2020" @default.
• W2969870895 type Work @default.
• W2969870895 sameAs 2969870895 @default.
• W2969870895 citedByCount "16" @default.
• W2969870895 countsByYear W29698708952020 @default.
• W2969870895 countsByYear W29698708952021 @default.
• W2969870895 countsByYear W29698708952022 @default.
• W2969870895 countsByYear W29698708952023 @default.
• W2969870895 crossrefType "journal-article" @default.
• W2969870895 hasAuthorship W2969870895A5007014216 @default.
• W2969870895 hasAuthorship W2969870895A5012411744 @default.
• W2969870895 hasAuthorship W2969870895A5018686666 @default.
• W2969870895 hasAuthorship W2969870895A5034219005 @default.
• W2969870895 hasAuthorship W2969870895A5047142547 @default.
• W2969870895 hasAuthorship W2969870895A5076345819 @default.
• W2969870895 hasAuthorship W2969870895A5082888818 @default.
• W2969870895 hasAuthorship W2969870895A5084594418 @default.
• W2969870895 hasAuthorship W2969870895A5087464605 @default.
• W2969870895 hasBestOaLocation W29698708951 @default.
• W2969870895 hasConcept C112705442 @default.
• W2969870895 hasConcept C126322002 @default.
• W2969870895 hasConcept C126894567 @default.
• W2969870895 hasConcept C141071460 @default.
• W2969870895 hasConcept C142724271 @default.
• W2969870895 hasConcept C203014093 @default.
• W2969870895 hasConcept C2776694085 @default.
• W2969870895 hasConcept C2777407522 @default.
• W2969870895 hasConcept C2778239845 @default.
• W2969870895 hasConcept C2779688492 @default.
• W2969870895 hasConcept C29730261 @default.
• W2969870895 hasConcept C54173615 @default.
• W2969870895 hasConcept C71924100 @default.
• W2969870895 hasConcept C76318530 @default.
• W2969870895 hasConceptScore W2969870895C112705442 @default.
• W2969870895 hasConceptScore W2969870895C126322002 @default.
• W2969870895 hasConceptScore W2969870895C126894567 @default.
• W2969870895 hasConceptScore W2969870895C141071460 @default.
• W2969870895 hasConceptScore W2969870895C142724271 @default.
• W2969870895 hasConceptScore W2969870895C203014093 @default.
• W2969870895 hasConceptScore W2969870895C2776694085 @default.
• W2969870895 hasConceptScore W2969870895C2777407522 @default.
• W2969870895 hasConceptScore W2969870895C2778239845 @default.
• W2969870895 hasConceptScore W2969870895C2779688492 @default.
• W2969870895 hasConceptScore W2969870895C29730261 @default.
• W2969870895 hasConceptScore W2969870895C54173615 @default.
• W2969870895 hasConceptScore W2969870895C71924100 @default.
• W2969870895 hasConceptScore W2969870895C76318530 @default.

• next